Global Medical Directory is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Connect with this vendor - Learn about this product
MBA Pharmaceuticals Pvt Ltd

OPDYTA 100/40 mg (Nivolumab)

Manufacturer : Bristol-Myers Squibb

Composition : Nivolumab 100/40 mg

Opdyta 100 mg Injection is used in the treatment of melanoma, non-small cell lung cancer, head and neck cancer, kidney cancer and non-Hodgkin lymphoma (NHL)

Features:

  • Accurate composition
  • Excellent result
  • Longer shelf life
Specialty: